Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

On April 13, 2023, the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine will convene a virtual, public workshop to explore the state of the science with ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue. The molecule took the team on a ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

The Cancer Research Institute launches a first-of-its-kind open-access database to help scientists better understand how the immune system responds to cancer treatments over time. The collaborative ...

Cancer genomics has revolutionised our understanding of tumour biology by deciphering the complex genetic alterations that underpin oncogenesis. Central to this field is the identification and ...

A hidden communication network between brain cells and glioblastoma tumors may be key to slowing this aggressive cancer.